162 related articles for article (PubMed ID: 31190876)
1. ITGBL1 promotes EMT, invasion and migration by activating NF-κB signaling pathway in prostate cancer.
Li W; Li S; Yang J; Cui C; Yu M; Zhang Y
Onco Targets Ther; 2019; 12():3753-3763. PubMed ID: 31190876
[No Abstract] [Full Text] [Related]
2. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
[TBL] [Abstract][Full Text] [Related]
4. ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma.
Huang W; Yu D; Wang M; Han Y; Lin J; Wei D; Cai J; Li B; Chen P; Zhang X
Cell Prolif; 2020 Jul; 53(7):e12836. PubMed ID: 32537856
[TBL] [Abstract][Full Text] [Related]
5. Jianpi Jiedu Recipe inhibits colorectal cancer liver metastasis via regulating ITGBL1-rich extracellular vesicles mediated activation of cancer-associated fibroblasts.
Li R; Zhou J; Wu X; Li H; Pu Y; Liu N; Han Z; Zhou L; Wang Y; Zhu H; Yang L; Li Q; Ji Q
Phytomedicine; 2022 Jun; 100():154082. PubMed ID: 35381565
[TBL] [Abstract][Full Text] [Related]
6. ITGBL1 Predicts a Poor Prognosis and Correlates EMT Phenotype in Gastric Cancer.
Li R; Zhuang C; Jiang S; Du N; Zhao W; Tu L; Cao H; Zhang Z; Chen X
J Cancer; 2017; 8(18):3764-3773. PubMed ID: 29151964
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
8. AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling.
Wang B; Gu Y; Hui K; Huang J; Xu S; Wu S; Li L; Fan J; Wang X; Hsieh JT; He D; Wu K
Urol Oncol; 2018 Oct; 36(10):472.e11-472.e20. PubMed ID: 30139661
[TBL] [Abstract][Full Text] [Related]
9. Aphthous ulcer drug inhibits prostate tumor metastasis by targeting IKKɛ/TBK1/NF-κB signaling.
Cheng C; Ji Z; Sheng Y; Wang J; Sun Y; Zhao H; Li X; Wang X; He Y; Yao J; Wang L; Zhang C; Guo Y; Zhang J; Gao WQ; Zhu HH
Theranostics; 2018; 8(17):4633-4648. PubMed ID: 30279728
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
[TBL] [Abstract][Full Text] [Related]
12. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer.
Qiu X; Feng JR; Qiu J; Liu L; Xie Y; Zhang YP; Liu J; Zhao Q
Biomed Pharmacother; 2018 Aug; 104():172-180. PubMed ID: 29772438
[TBL] [Abstract][Full Text] [Related]
13. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of PARVA promotes metastasis by modulating integrin-linked kinase activity and regulating MAPK/ERK and MLC2 signaling in prostate cancer.
Huang C; Shen Q; Song G; He S; Zhou L
Transl Androl Urol; 2021 Feb; 10(2):915-928. PubMed ID: 33718092
[TBL] [Abstract][Full Text] [Related]
15. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
[TBL] [Abstract][Full Text] [Related]
16. Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB Signaling.
Wa Q; Zou C; Lin Z; Huang S; Peng X; Yang C; Ren D; Xu D; Guo Y; Liao Z; Wang B; Hu H; Huang S; He P
Mol Ther Oncolytics; 2020 Jun; 17():267-277. PubMed ID: 32368615
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of ITGBL1 predicts poor prognosis and promotes chemoresistance in ovarian cancer.
Song J; Yang P; Lu J
Cancer Biomark; 2020; 27(1):51-61. PubMed ID: 31683459
[TBL] [Abstract][Full Text] [Related]
18. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells.
Liu C; Guan H; Wang Y; Chen M; Xu B; Zhang L; Lu K; Tao T; Zhang X; Huang Y
PLoS One; 2015; 10(12):e0144073. PubMed ID: 26650737
[TBL] [Abstract][Full Text] [Related]
19. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.
Shen H; Ma JL; Zhang Y; Deng GL; Qu YL; Wu XL; He JX; Zhang S; Zeng S
World J Gastroenterol; 2016 Apr; 22(15):3969-77. PubMed ID: 27099440
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic downregulated ITGBL1 promotes non-small cell lung cancer cell invasion through Wnt/PCP signaling.
Gan X; Liu Z; Tong B; Zhou J
Tumour Biol; 2016 Feb; 37(2):1663-9. PubMed ID: 26307393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
